What INNOTERE does

INNOTERE GmbH is a German developer and manufacturer of calcium phosphate-based biomaterials and medical devices for bone repair and regeneration, headquartered at Pharmapark Radebeul (Meissner Strasse 191, Germany). Founded in 2004, the company operates a proprietary, patented technology platform that transforms calcium phosphate cements into ready-to-use medical devices, organized across three product families: Medical Devices (Paste-CPC injectable bone cement paste, macroporous 3D Scaffolds, and Patient Specific Implants derived from CT data), Biomaterials (high-purity alpha-TCP, beta-TCP, and hydroxyapatite powders), and 3D Printing consumables (Plotter-Paste-CPC, cell culture scaffolds). It also maintains a parallel veterinary product line and offers regulatory and quality management consulting based on its Class III certification experience.

The company sells primarily through direct, contact-based sales to hospitals, orthopedic clinics, veterinary practices, and academic research institutions globally, with a stated global footprint in 3D printing equipment and biomaterials supply. INNOTERE is certified to EN ISO 13485 and is the first and only company with MDR 2017/745 certification in Class III for a 3D-printed scaffold product family, representing a defensible regulatory position. In October 2025, INNOTERE was integrated into Heraeus Medical's regenerative orthopedics portfolio, bringing its cement and 3D-printed scaffold capabilities under a major global orthopedics platform. Prior to the integration, INNOTERE was a privately held GmbH with 11–50 employees and limited public financial disclosure.

Name

INNOTERE

Legal name

INNOTERE GmbH

Website

https://innotere.de

Company type

Private

Founded year

2004

Operating status

Operating

Headcount range

11–50 employees

Short description

INNOTERE GmbH is a German developer and manufacturer of proprietary calcium phosphate bone cements, 3D-printed scaffolds, and patient-specific implants for orthopedic and veterinary bone repair, certified to MDR Class III and integrated into Heraeus Medical in October 2025.

Ownership category

akta.pro rank

Product category

Orthobiologic Bone Replacement Materials

NAICS

Surgical Appliance and Supplies Manufacturing (339113)

SIC

Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)

akta.pro primary industry

Bone Graft Substitutes & Orthobiologics (Synthetic/Allograft/DBM) (HLAHAEAG)

akta.pro secondary industries

Tissue-Engineered Constructs & Scaffolds (natural/synthetic biomaterials) (HLAAAGAB), 3D-Printed & Patient-Specific Implants (Custom Ortho/Spine/Cranial) (HLAHAEAJ), Tissue Engineering & Biomaterial Scaffolds (HLAMANAC), Medical & Dental 3D Printing Services (patient-specific devices, dental labs) (IMAAADAG)

Keywords

• Calcium phosphate bone cement
• Orthobiologics manufacturing
• Bone graft substitutes
• 3D printed scaffolds
• Patient specific implants

Headquarters

HQ city

Radebeul

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Operations, Personnel, Supply Chain, Marketing or Sales

Distribution channels3 records

Marketing channels4 records

Core offering

INNOTERE GmbH develops and manufactures calcium phosphate-based bone substitute materials and 3D-printed scaffolds for human and veterinary orthopedics. Its portfolio spans ready-to-use injectable Paste-CPC bone cement, macroporous 3D scaffolds, patient-specific implants derived from CT data, and medical-grade calcium phosphate powders (Alpha-TCP, Beta-TCP, Hydroxyapatite). The company also supplies 3D-printing materials and offers medical device regulatory consulting.

Product overview

INNOTERE is a key contributor in orthobiologics development and manufacturing, specializing in innovative calcium phosphate-based cements. The company operates as a unified product platform built around proprietary calcium phosphate cement technology, organized into three main product families: Medical Devices (Paste-CPC, 3D Scaffold, Patient Specific Implants), Biomaterials (Alpha-TCP, Beta-TCP, Hydroxyapatite), and 3D Printing (Plotter-Paste-CPC, Cell Culture Scaffolds). A dedicated Veterinary line mirrors these products for animal health applications. The company also offers consulting services leveraging over 10 years of MDR Class III certification experience for 3D-printed scaffolds. In October 2025, INNOTERE was integrated into Heraeus Medical's regenerative orthopedics portfolio.

Differentiator

Problem solved

Functional benefit

Products and services

• INNOTERE Paste-CPC Ready-to-use injectable calcium phosphate bone cement paste for bone void filling in human and veterinary orthopedic surgery. Sets only after contact with aqueous liquids, eliminating intraoperative time pressure.
• INNOTERE 3D Scaffold Macroporous, synthetic, biocompatible, osteoconductive and bioresorbable 3D-printed calcium phosphate scaffold for guided bone regeneration in human and veterinary orthopedic surgery.
• INNOTERE Patient Specific Implants (PSI) Patient-specific, apatitic implants for reconstructing or supporting individual bone defects, manufactured from CT data with customizable macroporosity and geometry per surgeon requirements.
• Alpha-Tricalcium Phosphate (Alpha-TCP) Medical-grade alpha-tricalcium phosphate powder with >99% phase purity and batch-to-batch reproducibility, used in bone cements, bone graft substitutes, coatings, and 3D printing.
• Beta-Tricalcium Phosphate (Beta-TCP) Medical-grade beta-tricalcium phosphate powder with >98% phase purity, providing an ideal scaffold for bone regeneration with balanced resorption behavior.
• Hydroxyapatite Highly bioactive, medical-grade hydroxyapatite supplied in granules and fine powder forms, manufactured from alpha-TCP-based cement using INNOTERE's innovative 3D-printing process.
• Plotter-Paste-CPC Calcium phosphate cement paste for 3D extrusion printing of compact or porous scaffolds with high dimensional accuracy, used as a 3D-printing consumable material.
• Cell Culture Scaffolds Ready-packaged, gamma-sterilized calcium phosphate scaffolds with interconnected porosity available in standardized 2D and 3D geometries for cell culture research in bone regeneration.
• INNOTERE Veterinary Paste-CPC Ready-to-use, self-setting synthetic calcium phosphate bone substitute for minimally invasive application in veterinary orthopedic surgery.
• INNOTERE Veterinary Granules Highly uniform calcium phosphate granules manufactured via INNOTERE's 3D-printing process for veterinary bone substitution applications.
• INNOTERE Veterinary Scaffolds 3D-printed calcium phosphate scaffolds offered in cylindrical, cubic, or wedge shapes in various sizes for veterinary bone regeneration applications.
• INNOTERE Veterinary Powder-CPC Calcium phosphate powder with mixing syringe for preparation of injectable bone substitute with optional antibiotic release properties for veterinary use.
• Medical Device Consulting Services Consulting services covering conceptual design, technical documentation, MDR 2017/745 compliance, quality management system establishment, and certification support for orthobiologic medical device manufacturers.

Quantifiable outcome

• Compressive strength up to 35 MPa within a few days after application
• +2 more outcomes

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Two partnerships are on record, tiered major and minor.

• Heraeus MedicalmajorStrategic or Co-development Partner · 1 October 2025Heraeus Medical expanded its regenerative orthopedics portfolio in October 2025 through integration of INNOTERE GmbH. This integration brought INNOTERE's calcium phosphate cement technology and 3D-printed scaffold capabilities into Heraeus Medical's portfolio, strengthening their position in orthobiologics.
• TheraVet SAminorChannel Partner/ Reseller/ DistributorTheraVet SA previously distributed INNOTERE's veterinary products exclusively under the trade names BIOCERA-VET Bone Surgery RTU, BIOCERA-VET Bone Surgery Equine, BIOCERA-VET Bone Surgery Granules, and BIOCERA-VET Osteosarcoma RTU. Products are now offered under INNOTERE Veterinary brand.

Scale indicators2 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Xilloc: Dutch company specializing in 3D-printed patient-specific implants for cranial, orthopedic, and reconstructive surgery. Direct peer to INNOTERE's Patient-Specific Implants offering.
• Kasios: French manufacturer of synthetic bone graft substitutes including calcium phosphate cements and TCP-based products for spine, trauma, and dental surgery. Direct peer in synthetic bone void fillers.
• Curasan: German manufacturer of bone regeneration materials, including synthetic bone graft substitutes and dental bone replacement products. Comparable to INNOTERE's bone void-filler portfolio with a focus on dental/orthopedic use.
• Biomatlante: Specialist in calcium phosphate-based bone substitutes and macroporous scaffolds for orthopedic and dental surgery. Closely comparable to INNOTERE's calcium phosphate cement and 3D scaffold portfolio.
• Noraker: French manufacturer of synthetic calcium phosphate bone graft substitutes (MBCP technology) for orthopedic, spinal, and dental indications. Direct peer given shared calcium phosphate cement platform and bone void-filler focus.
• Bonalive Biomaterials: Finnish company producing bioactive glass and synthetic bone graft substitutes for orthopedic and dental bone regeneration. Comparable as a niche European synthetic bone-substitute specialist.
• Botiss Biomaterials: Provider of bone and soft tissue regeneration materials, including synthetic bone graft substitutes and 3D-printed scaffolds for dental and orthopedic applications. Direct overlap in synthetic bone substitutes and 3D scaffolds.

Broad incumbents

• Stryker (Orthobiologics): Global orthopedic medical device leader with a broad orthobiologics portfolio (bone graft substitutes, regenerative materials). Comparable as a large incumbent selling into the same hospital channels as INNOTERE.
• Bioventus: Pure-play orthobiologics company offering bone graft substitutes, hyaluronic acid, and ultrasonic bone healing products. Comparable as a focused orthobiologics incumbent competing in bone repair and regeneration.
• Medtronic (Orthobiologics): Diversified medical device giant with a substantial orthobiologics and spine business, including bone graft substitutes. Comparable as a broad incumbent competing in the same bone repair indications.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/innotere-gmbh

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about INNOTERE